How would you approach a stage 1 HR+/HER2- pre-menopausal patient <50 years old with Oncotype DX RS of 24?   

Would you offer this patient chemotherapy? What are your thoughts about OFS plus AI and avoiding chemotherapy?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Siri Onclogy and hematology Infusion Service
I agree with the last two comments. No matter wha...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Icahn School of Medicine at Mount Sinai
The risk with endocrine therapy alone in the examp...
Sign in or Register to read more